• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17467

【品名】(2-aminophenyl)(4-fluorophenyl)methanone

【CA登记号】

【 分 子 式 】C13H10FNO

【 分 子 量 】215.2269432

【元素组成】C 72.55% H 4.68% F 8.83% N 6.51% O 7.43%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(LIV)

6) Synthesis of the quinoline (XXI): Anthranilic acid (LI) is tolylated with tosyl chloride and treated with PCl5 in 1,2-dichloroethane to give the corresponding acyl chloride (LII), which is submitted to a Friedel Crafts condensation with fluorobenzene (LIII)/AlCl3 yielding 2-amino-4'-fluorobenzophenone (LIV). The cyclization of (LIV) with ethyl 2-(cyclopropylcarbonyl)acetate (LV) [obtained by condensation of cyclopropyl methyl ketone (LVI) and diethyl carbonate (LVII) with H2SO4] by means of p-toluenesulfonic acid yields 2-cyclopropyl-4-(4-fluorophenyl)-quinoline-3-carboxylic acid ethyl ester (LVIII), which is submitted to a decarboxylative iodination with I2 and acetyl peroxide to afford 2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline (XXI). 7) Synthesis of the quinoline (XXXVII): The reduction of the quinolinecarboxylate (LVIII) with LiAlH4 in THF gives the corresponding methanol derivative (LIX), which is then treated with diphenyl disulfide (LX) and tri-butylphosphine in pyridine to afford 2-cyclopropyl-4-(4-fluorophenyl)-3-(phenylsulfanylmethyl)quinoline (XXXVII).

1 Castaner, J.; Sorbera, L.A.; Leeson, P.A.; NK-104. Drugs Fut 1998, 23, 8, 847-859.
2 Kamikubo, T.; Takano, S.; Sugihara, T.; Suzuki, M.; Ogasawara, K.; Enantioconvergent synthesis of a promising HMG-CoA reductase inhibitor NK-104 from both enantiomers of epichlorohydrin. Tetrahedron Asymmetry 1993, 4, 2, 201-4.
3 Iwasaki, H.; Miyachi, N.; Yanagawa, Y.; Ohara, Y.; Hiyama, T.; A novel synthetic method of HMG-CoA reductase inhibitor NK-104 via a hydroboration-cross-coupling sequence. Tetrahedron Lett 1993, 34, 51, 8267-70.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXI) 17435 2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline C18H13FIN 详情 详情
(XXXVII) 17451 [2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methyl phenyl sulfide; 2-cyclopropyl-4-(4-fluorophenyl)-3-[(phenylsulfanyl)methyl]quinoline C25H20FNS 详情 详情
(LI) 11661 2-Aminobenzoic acid;Anthranilic acid; o-Aminobenzoic acid 118-92-3 C7H7NO2 详情 详情
(LII) 17465 2-aminobenzoyl chloride C7H6ClNO 详情 详情
(LIII) 17466 Fluorobenzene 462-06-6 C6H5F 详情 详情
(LIV) 17467 (2-aminophenyl)(4-fluorophenyl)methanone C13H10FNO 详情 详情
(LV) 15949 3-Cyclopropyl-3-oxo-propionic acid ethyl ester; ethyl 3-cyclopropyl-3-oxopropanoate 24922-02-9 C8H12O3 详情 详情
(LVI) 12435 Acetylcyclopropane; 1-Cyclopropyl-1-ethanone; Cyclopropylmethylketone 765-43-5 C5H8O 详情 详情
(LVII) 17470 diethyl carbonate; diethylcarbonate 105-58-8 C5H10O3 详情 详情
(LVIII) 17471 ethyl 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylate C21H18FNO2 详情 详情
(LIX) 17472 [2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methanol C19H16FNO 详情 详情
(LX) 17473 diphenyl disulfide; 1-(phenyldisulfanyl)benzene; diphenyldisulfide 882-33-7 C12H10S2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

A synthesis of pitavastatin has been reported: Cyclization of 2-amino-4'-fluorobenzophenone (I) with 3-cyclopropyl-3-oxopropionic acid methyl ester (II) by means of H2SO4 in refluxing acetic acid or methanesulfonic acid in refluxing benzene gives 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylic acid methyl ester (III), which is reduced with DIBAL in toluene to yield the carbinol (IV). Oxidation of compound (IV) with PCC and AcONa in dichloromethane affords carbaldehyde (V), which is condensed with tributylstannane (VI) by means of BuLi in THF to provide the enol ether (VII). Hydrolysis of (VII) by means of TsOH in THF/water gives the unsaturated carbaldehyde (VIII), which is condensed with acetoacetic ester (IX) by means of NaH and BuLi in THF to yield the 5-hydroxy-3-oxoheptenoic ester derivative (X). Stereoselective reduction of the oxo group of (X) by means of diethylmethoxyborane and NaBH4 in THF/methanol gives the racemic syn-dihydroxy compound (XI) in a syn/anti ratio of 98:2. Finally, compound (XI) is hydrolyzed with NaOH in aqueous ethanol to yield racemic pitavastatin sodium. Alternatively, the unsaturated carbaldehyde (VIII) can also be obtained by reaction of carbaldehyde (V) with phosphonate (XII) by means of NaOH in toluene/water to give the unsaturated nitrile (XIII), which is finally reduced with DIBAL in toluene to afford the target carbaldehyde (VIII).

1 Fujikawa, Y.; Suzuki, M.; Iwasaki, H.; Kitahara, M.; Sakashita, M.; Sakoda, R.; Synthesis and biological evaluations of quinolone-based HMG-CoA reductase inhibitors. Bioorg Med Chem 2001, 9, 10, 2727.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17467 (2-aminophenyl)(4-fluorophenyl)methanone C13H10FNO 详情 详情
(II) 51482 Methyl 3-cyclopropyl-3-oxopropanoate 32249-35-7 C7H10O3 详情 详情
(III) 51483 methyl 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylate C20H16FNO2 详情 详情
(IV) 17472 [2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]methanol C19H16FNO 详情 详情
(V) 17425 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarbaldehyde 121660-37-5 C19H14FNO 详情 详情
(VI) 51484 ethyl (E)-2-(tributylstannyl)ethenyl ether; tributyl[(E)-2-ethoxyethenyl]stannane C16H34OSn 详情 详情
(VII) 51485 (E)-1-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3-ethoxy-2-propen-1-ol C23H22FNO2 详情 详情
(VIII) 39666 (E)-3-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenal C21H16FNO 详情 详情
(IX) 11819 ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate 141-97-9 C6H10O3 详情 详情
(X) 39667 ethyl (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate C27H26FNO4 详情 详情
(XI) 51486 ethyl (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate C27H28FNO4 详情 详情
(XII) 10045 Diethyl cyanomethylphosphonate 2537-48-6 C6H12NO3P 详情 详情
(XIII) 39665 (E)-3-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile C21H15FN2 详情 详情
Extended Information